Baijiu plate strength, mouth cellar line exceeds 10%

Synthetic Biology: Who Will Emerge as the Winner?

The 21st century is the century of biology. Synthetic biology is believed to be a ‘World Changing’ industry. But the potential risks like cost control and commercialization pathways are fatefully tied to the ups and downs of countless investment decisions and the destiny of the many new start-ups getting involved. We look forward to seeing an emerging ‘giant’ on the horizon of this exciting industry.

Can Douyin Grab a Slice of The Food Delivery Market From Meituan?

On March 24th, Meituan (Chinese: 美团) had its Q4 2022 earnings call. This article reviews its key performance under the context of Douyin's entry into local services and future strategy outlook.

Surgerii Robotics: Single-Port Surgical Robots Poised to Transform Surgery

The worldwide surgical robotic market is expected to grow at a booming CAGR of 5.8% during 2022 to 2030, rising from USD 5.05 billion in 2022 to USD 21.41 billion in 2030. Of which, the single-port surgical robots that result in less pain, fewer scars, and quicker recovery, have tremendous up potential.

Kuaishou Profits In Reducing Costs And Improving Efficiency

Kuaishou has achieved remarkable results in reducing costs and improving efficiency, and the domestic business will turn losses into profits in 2022.

Bloomage: Injecting Biotechnology into Beauty Care

Listed on the Chinese Star Market in November 2019, Bloomage was trading at CNY 138.01 as of June 24, 2020, over 38% higher than the IPO price of CNY 100.